SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-16-113822
Filing Date
2016-04-25
Accepted
2016-04-25 17:05:57
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM a16-8955_1posam.htm POS AM 526538
2 EX-23.1 a16-8955_1ex23d1.htm EX-23.1 3404
3 GRAPHIC g89551bei001.jpg GRAPHIC 4339
4 GRAPHIC g89551hoi001.jpg GRAPHIC 5548
  Complete submission text file 0001104659-16-113822.txt   544998
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-207533 | Film No.: 161589626
SIC: 2834 Pharmaceutical Preparations